4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000950170-25-089609
Director acquired 29,600 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Duncan Barbara Gayle Director | 2025-06-20 | Option exercise | +29,600 | 62,750 | D | ||
| Derivatives | |||||||
| Duncan Barbara Gayle Director | 2025-06-20 | Grant or award · Restricted Stock Units | +29,600 | 29,600 | D | ||
| Duncan Barbara Gayle Director | 2025-06-20 | Grant or award · Stock Option (Right to Buy) | +41,200 | 41,200 | D | ||
| Duncan Barbara Gayle Director | 2025-06-20 | Option exercise · Restricted Stock Units | −29,600 | 0 | D | ||
Loading xslF345X05/ownership.xml…